Showing results (91-100 of 127) with videos related to

Sort By:
Pageof 13
The Journal of Clinical Investigation|March 1, 1981
Importance of the vasoactive intestinal peptide receptor in the stimulation of cyclic adenosine 3',5'-monophosphate in gallbladder epithelial cells of man. Comparison with the guinea pigC Dupont, J P Broyart, Y Broer, et al.
The Journal of Biological Chemistry|February 10, 1981
Structural requirements for glucagon receptor binding and activation of adenylate cyclase in liver. Study of chemically modified forms of the hormone, including N alpha-trinitrophenyl glucagon, an antagonistR M Epand, G Rosselin, D H Hoa, et al.
The American Journal of Physiology|March 1, 1992
Neurotensin and neuromedin N stimulate mucin output from human goblet cells (Cl.16E) via neurotensin receptorsC Augeron, T Voisin, J J Maoret, et al.
The Journal of Biological Chemistry|May 31, 1996
Vasoactive intestinal peptide (VIP)1 receptor. Three nonadjacent amino acids are responsible for species selectivity with respect to recognition of peptide histidine isoleucineamideA Couvineau, C Rouyer-Fessard, J J Maoret, et al.
Biochemical and Biophysical Research Communications|June 15, 1984
Structural requirements for VIP interaction with specific receptors in human and rat intestinal membranes: effect of nine partial sequencesA Couvineau, C Rouyer-Fessard, A Fournier, et al.
Endocrinology|July 1, 1987
Galanin receptors in a hamster pancreatic beta-cell tumor: identification and molecular characterizationB Amiranoff, A L Servin, C Rouyer-Fessard, et al.
Peptide Research|September 1, 1988
Syntheses and receptor affinities of partial sequences of peptide YY (PYY)A Balasubramaniam, A L Servin, D F Rigel, et al.
Peptides|September 1, 1993
Structure-activity studies of peptide YY(22-36): N-alpha-Ac-[Phe27]PYY(22-36), a potent antisecretory peptide in rat jejunumA Balasubramaniam, H M Cox, T Voisin, et al.
Biochemical and Biophysical Research Communications|January 5, 1995
Highly conserved aspartate 68, tryptophane 73 and glycine 109 in the N-terminal extracellular domain of the human VIP receptor are essential for its ability to bind VIPA Couvineau, P Gaudin, J J Maoret, et al.
Cancer Research|July 1, 1980
Vasoactive intestinal peptide control of cyclic adenosine 3':5'-monophosphate levels in seven human colorectal adenocarcinoma cell lines in cultureM Laburthe, M Rousset, G Chevalier, et al.
Pageof 13